MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


FTSE opens higher, led by AstraZeneca ahead of vaccine approval

StockMarketWire.com

UK stocks opened higher, led by AstraZeneca on expectations that its coronavirus vaccine could be approved for use as soon as Tuesday.

At 08:30, the benchmark FTSE 100 index was up 109 points, or 1.68%, at 6,611.64.

Drugmaker AstraZeneca was among the biggest gainers, up 4% to £75.52, on reports that health regulators in the UK could announce their decision to approve the vaccine for use on Tuesday.

AstraZeneca also reported that it had won approval in Japan for a drug to treat three cancers.

Insurance company Admiral climbed 3% to £30.11 after reaching an agreement to sell Penguin Portals and Preminen comparison businesses to RVU, the comparison division of ZPG, for £508 million.

Betting company William Hill was up 0.2% to 270.5p after announcing that its £2.9 billion sale to Caesars was expected to be completed in the second quarter of 2021.

Shearwater jumped 10% to 154.5p after the cybersecurity and risk management company said revenue growth seen in October and November had continued into December, and also announced new business wins.





Story provided by StockMarketWire.com